Prostate Cancer Update cover art

Prostate Cancer Update

Prostate Cancer Update

By: Dr. Neil Love
Listen for free

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.Copyright 2025 Research To Practice. All Rights Reserved Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

    Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
    May 26 2026

    Professor Thomas Powles from Barts Cancer Institute in London, United Kingdom, discusses recent developments with circulating tumor DNA assays in the management of urothelial bladder cancer.

    CME information and select publications here.

    Show More Show Less
    30 mins
  • PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida

    PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida
    May 15 2026

    Dr Wassim Abida from Memorial Sloan Kettering Cancer Center in New York, New York, discusses the role of PARP inhibitors in the management of hormone-sensitive and castration-resistant metastatic prostate cancer.

    CME information and select publications here.
    Show More Show Less
    52 mins
  • Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances

    Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
    Apr 17 2026

    Dr Andrew J Armstrong from the Duke Cancer Institute in Durham, North Carolina, and Dr Scott T Tagawa from Weill Cornell Medicine Meyer Cancer Center in New York, New York, discuss the selection and sequencing of therapy for patients with prostate cancer and summarize major advances in the treatment landscape over the past year.

    CME information and select publications here.
    Show More Show Less
    58 mins
adbl_web_anon_alc_button_suppression_c
No reviews yet